Paper Details

  1. Home
  2. Paper Details

Intraoperative and postoperative complications for repeat high-grade glioma resections with concurrent chemotherapy: patient series.

Author: HounjetCeline, MakarenkoSerge, OngKenneth

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

High-grade gliomas are aggressive brain tumors that have a poor prognosis. The standard chemotherapy treatments include temozolomide, procarbazine, lomustine, and vincristine. It is not clear if chemotherapy should be withheld during surgery to remove the tumor, as the risks of doing so are not well-defined.
Paper Details　
Original Abstract of the Article :
High-grade gliomas are aggressive primary brain tumors, the most common of which is glioblastoma multiforme. Despite advances in treatment, the prognosis for these patients remains poor. The most common chemotherapeutic agents used in the treatment of this pathology include temozolomide (TMZ), proca...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10584083/

データ提供：米国国立医学図書館（NLM）

Navigating the Complexities of Repeat Glioma Resections with Chemotherapy

The field of [Neuro-Oncology] is constantly seeking ways to improve outcomes for patients with [High-Grade Gliomas], particularly [Glioblastoma Multiforme]. This research delves into the management of [repeat high-grade glioma resections with concurrent chemotherapy]. The researchers examine the [perioperative risk profile] associated with this complex treatment strategy. Their findings highlight the need for careful consideration of the [potential complications] associated with [concurrent chemotherapy] during resection, emphasizing the importance of [individualized treatment planning] to minimize risks and maximize benefits for patients.

A Balancing Act: Optimizing Treatment Strategies

This study sheds light on the delicate balance between aggressive surgical intervention and chemotherapy in managing high-grade gliomas. The findings underscore the need for a personalized approach that carefully weighs the potential benefits and risks of concurrent chemotherapy during resection.

The Desert of Brain Tumor Treatment: A Challenging Journey

The desert of brain tumor treatment is unforgiving, with challenging decisions and potential complications. This study underscores the importance of a comprehensive and collaborative approach to managing these complex cases, ensuring that patients receive the most appropriate and individualized care.

Dr. Camel's Conclusion

This study delves into the complexities of managing repeat high-grade glioma resections with concurrent chemotherapy, highlighting the importance of individualizing treatment planning to minimize risks and maximize benefits for patients.

Date :
  1. Date Completed n.d.
  2. Date Revised 2023-10-26
Further Info :

Pubmed ID

37870760

DOI: Digital Object Identifier

PMC10584083

Related Literature

Article Analysis
・Effects of lomustine
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.